Skin cancer: Basal cell carcinoma: Genetic homogeneity in a tumour type displaying phenotypic diversity

European Journal of Human Genetics

Volumn 14, Issue 9, 2006, Pages 977-978

  Hoban, Paul R ^a   Lear, John T ^b   Strange, Richard C ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; IMIQUIMOD; PROTEIN PATCHED; REACTIVE OXYGEN METABOLITE; SONIC HEDGEHOG PROTEIN; CELL SURFACE RECEPTOR; DROSOPHILA PROTEIN; HEDGEHOG PROTEIN, DROSOPHILA; PATCHED RECEPTORS; TRANSACTIVATOR PROTEIN;

BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CANCER GENETICS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CHROMOSOME 9Q; DNA MICROARRAY; GENE INACTIVATION; GENE LOCATION; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HUMAN; MICROSATELLITE MARKER; NONHUMAN; NOTE; PHENOTYPIC VARIATION; PHOTODYNAMIC THERAPY; PLASTIC SURGERY; PRIORITY JOURNAL; RECURRENCE RISK; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CARCINOGENESIS; SKIN SURGERY; SUN EXPOSURE; ANIMAL; ARTICLE; DISEASE MODEL; GENETICS; METABOLISM; PHENOTYPE; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOMA, BASAL CELL; DISEASE MODELS, ANIMAL; DROSOPHILA PROTEINS; HEDGEHOG PROTEINS; HUMANS; PHENOTYPE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TRANS-ACTIVATORS; ULTRAVIOLET RAYS;

EID: 33747757542     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201658     Document Type: Note

References (13)

1. Teh MT, Blaydon D, Chaplin T et al: Genome wide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 2005; 65: 8597-8603.
2. Armstrong BK, Kricker A: The Epidemiology of UV induced skin cancer J. J Photochem Photobiol B Biol 2001; 63: 8-18.
3. Quinn AG, Sikkink S, Rees JL: Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 1994; 54: 4756-4759.
4. Hooper JE, Scott MP: Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005; 6: 306-317.
5. Azsterbaum M, Rothman A, Johnson RL et al: Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest dermatol 1998; 110: 885-888.
6. Athar M, Li C, Tang X et al: Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res 2004; 64: 7545-7552.
7. McCormack CJ, Kelly JW, Dorevitch AP: Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. Arch Dermatol 1997; 133: 593-596.
8. Hoban PR, Ranachandran S, Strange RC: Environment phenotype and genetics: Risk factors associated with basal cell carcinoma of the skin. Expert Rev Cancer Treat 2002; 2: 570-581.
9. Mancuso M, Pazzaglia S, Tanori M et al: Basal cell carcinoma and its development: Insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res 2004; 64: 934-941.
10. Strange RC, El-Genidy N, Ramachandran S et al: Susceptibility to basal cell carcinoma: Associations with PTCH polymorphisms. Ann Hum Genet 2004; 68: 536-545.
11. Bailey EC, Milenkovic L, Scott MP, Collawn JF, Johnson RL: Several PATCHD1 missense mutations display activity in patched1-deficient fibroblasts. J Biol Chem 2002; 277: 33632-33640.
12. Thomas C, Ingham P: Hedgehog signaling in the Drosophila eye and head: an analysis of the effects of different patched transheterozygotes. Genetics 2003; 165: 1915-1928.
13. Pazzaglia S, Mancuso M, Tanori M et al: Modulation of patched-associated susceptibility to radiation induced tumorigenesis by genetic background. Cancer Res 2004; 64: 3798-3806.